Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
This funding opportunity supports research projects that explore innovative ways to improve cancer communication and health outcomes using modern technologies and methodologies, targeting institutions, nonprofits, and government entities involved in cancer prevention and care.
Description
The NIH's National Cancer Institute (NCI) is issuing this funding opportunity to support research in cancer communication. This initiative invites projects that explore innovative approaches to understanding and improving cancer communication in today’s information ecosystem. Areas of interest include using new surveillance methods, developing rapid interventions, and creating multilevel communication models. Research should focus on outcomes like cancer prevention, control, and survivorship, and must employ novel methodologies such as social media analysis, NLP, and AI tools. Applicants are encouraged to propose multilevel, data-driven studies applicable across diverse contexts, including health systems, communities, and online platforms.
The overarching goal is to reduce cancer-related risks and mortality while improving survivors' quality of life. Projects should align with this mission by addressing communication challenges like misinformation, enhancing patient-centered care, and promoting positive health behaviors (e.g., screening, sun protection). The use of innovative communication tools and platforms to improve health literacy, trust, and decision-making in cancer care is strongly emphasized.
Applications for new, renewal, or resubmission projects are accepted. Budgets are capped at $500,000 annually in direct costs, with project durations of up to five years. Eligible applicants include higher education institutions, nonprofits, state and local governments, and federally recognized tribal entities. Both clinical trial and non-clinical trial applications are accepted. Cost-sharing is not required, and multiple applications are permitted if each is scientifically distinct.
Applications must adhere to NIH submission guidelines, including SAM and Grants.gov registration, and use the NIH ASSIST system or equivalent institutional solutions. Required components include the SF424 (R&R) application package, a research plan detailing significance, innovation, and approach, and a data management and sharing plan. Proposals must demonstrate feasibility, rigor, and relevance to cancer communication science and control.
Review criteria focus on the importance of the research, the rigor and feasibility of the approach, and the qualifications of the investigators. Proposals will be evaluated for their potential impact, innovative use of methodologies, and alignment with NIH priorities. The review process includes both scientific merit assessments and budget justifications.
Key dates include the earliest submission opening on January 5, 2025, with application deadlines on February 5, 2025, and June 5, 2025. Projects are anticipated to start in December 2025. Post-award requirements include compliance with NIH data-sharing policies and annual progress reports. For questions, applicants can contact designated program officials or support services for submission assistance.